Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001104659-20-126957)

Filing Details

Accession Number:
0001104659-20-126957
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-18 18:16:31
Reporting Period:
2020-11-16
Accepted Time:
2020-11-18 18:16:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
727510 Enzon Pharmaceuticals Inc. ENZN Biological Products, (No Disgnostic Substances) (2836) 222372868
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1074613 C Randolph Read C/O Enzon Pharmaceuticals, Inc.
20 Commerce Drive (Suite 135)
Cranford NJ 07016		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-16 50,450 $0.15 50,450 No 4 P Direct
Common Stock Acquisiton 2020-11-18 50,000 $0.16 100,450 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the weighted average purchase price of multiple transactions, with shares purchased at prices ranging from $0.1502 to $0.1511 per share. The reporting person hereby undertakes to provide, upon request by the U.S. Securities and Exchange Commission staff, the issuer or a stockholder of the issuer, full information regarding the number of shares purchased at each separate price.